COMPUTER SYSTEM AND APPARATUS FOR DETERMINING SENSITIVITY TO BREAST CANCER NEOADJUVANT CHEMOTHERAPY
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Aug 28, 2014
filing date -
Aug 30, 2013
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Sensitivity to breast cancer neoadjuvant chemotherapy is determined on the basis of a result of analysis of the expression level, by amplifying RNA extracted from a specimen collected from a subject, thereby preparing a measurement sample, and measuring an expression level of each specified gene with a use of using the measurement sample.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully